Genesist Overview
- Year Founded
-
2022
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Genesist General Information
Description
Developer of gene-editing therapeutics designed for cancer prevention and treatment. The company's platform utilizes CRISPR-(Clustered regularly interspaced short palindromic repeats) based technology to modify stromal cells, enabling the healthcare industry to reduce cancer metastasis and recurrence.
Contact Information
Website
www.genesist.bioCorporate Office
- 263 Farmington Avenue
- University of Connecticut Health Center
- Farmington, CT 06032
- United States
Corporate Office
- 263 Farmington Avenue
- University of Connecticut Health Center
- Farmington, CT 06032
- United States
Genesist Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 07-Apr-2025 | Completed | Out of Business | |||
| 2. Accelerator/Incubator | 01-Jan-2024 | Completed | Startup | |||
| 1. Accelerator/Incubator | 03-Feb-2023 | Completed | Startup |
Genesist FAQs
-
When was Genesist founded?
Genesist was founded in 2022.
-
Where is Genesist headquartered?
Genesist is headquartered in Farmington, CT.
-
What industry is Genesist in?
Genesist’s primary industry is Other Healthcare Technology Systems.
-
Is Genesist a private or public company?
Genesist is a Private company.
-
What is Genesist’s current revenue?
The current revenue for Genesist is .
-
How much funding has Genesist raised over time?
Genesist has raised $10K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process